Compound Reference

CJC-1295 (No DAC)

A short-acting GHRH analog (Mod-GRF 1-29)

GH secretagogueEvidence: preclinical / earlyRUO · WADA-prohibited
Research Use Only. Not FDA-approved; sold only as a research chemical. Many performance-adjacent peptides are also WADA-prohibited for tested athletes. Educational only — not medical advice.

What it is

CJC-1295 without DAC (often "Mod-GRF 1-29") is a short-acting GHRH analog, commonly paired with a ghrelin mimetic (see CJC-1295 + Ipamorelin).

Proposed mechanism

As a GHRH-receptor agonist it prompts a physiological, pulsatile GH release. Without the DAC (drug-affinity-complex) it is short-acting — unlike the DAC version, which binds albumin and lasts days.1

State of the evidence

Regulatory & status

Reconstitution (reference only)

Lab-handling reference only — not a preparation or dosing instruction: 2.5 mL (250 units) reconstitution solution. See the reconstitution calculator for the arithmetic. This page does not provide dosing guidance.

References

  1. GH secretagogues / GHRH analogs (review). rco2.9

Explore the full library & 75-compound reference →

For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.